Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease)

Randomized Controlled Trial to Evaluate the Effect of a Cognitive Behavioral Program and Resilient Model in the Treatment of Depression and Anxiety and Impact on the Quality of Life in End-Stage Renal Disease Patients

This study evaluates the effect of a single cognitive-behavioral intervention (CBI) in a control group against the same CBI plus the strengthening of resiliency skills in an experimental group, on ESRD patients.

Cognitive behavioral therapy has long been an alternative in the treatment of symptoms of depression and anxiety in patients with chronic diseases such as renal failure, however the combination of therapeutic approaches that include not only pathological but also another more positive approach (as the resilient model), represents a novel proposal for the treatment of negative psychological symptoms and improvement of the quality of life in these patients.

The inclusion of the resilient model in a cognitive behavioral intervention serves as a possibility of therapeutic target that could enhance the effectiveness of the treatment.

Inclusion Criteria:

• Older than 18, and younger than 61 years old
• Depression score in the Beck Depression Inventory (BDI) greater than 30 points.
• Anxiety score in the Beck Anxiety Inventory (BAI) greater than 40 points.
• Have not been hospitalized over the last 6 months
• Signing of informed consent

Exclusion Criteria:

• May not be able to communicate in the Spanish language.
• Presence of psychiatric comorbidity (suicide ideation or depressive or anxious).